Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Checkpoint Therapeutics Inc (NASDAQ: CKPT) closed at $3.98 in the last session, down -0.50% from day before closing price of $4.00. In other words, the price has decreased by -$0.50 from its previous closing price. On the day, 7.02 million shares were traded. CKPT stock price reached its highest trading level at $4.02 during the session, while it also had its lowest trading level at $3.98.
Ratios:
We take a closer look at CKPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.B. Riley Securities initiated its Buy rating on June 09, 2021, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when Oliviero James F III sold 10,331 shares for $3.15 per share. The transaction valued at 32,543 led to the insider holds 3,775,019 shares of the business.
Oliviero James F III sold 9,233 shares of CKPT for $31,485 on Feb 07 ’25. The CEO, President and Director now owns 3,785,350 shares after completing the transaction at $3.41 per share. On Feb 06 ’25, another insider, GRAY WILLIAM GARRETT, who serves as the Chief Financial Officer of the company, sold 74,110 shares for $3.67 each. As a result, the insider received 271,984 and left with 1,458,644 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 194353344 and an Enterprise Value of 189650352. For the stock, the TTM Price-to-Sale (P/S) ratio is 3887.07. Its current Enterprise Value per Revenue stands at 4035.114.
Stock Price History:
The Beta on a monthly basis for CKPT is 1.20, which has changed by 1.1513515 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is 26.28%, while the 200-Day Moving Average is calculated to be 41.93%.
Shares Statistics:
According to the various share statistics, CKPT traded on average about 2.52M shares per day over the past 3-months and 8432450 shares per day over the past 10 days. A total of 45.10M shares are outstanding, with a floating share count of 35.93M. Insiders hold about 26.43% of the company’s shares, while institutions hold 22.07% stake in the company. Shares short for CKPT as of 1740700800 were 7154701 with a Short Ratio of 2.84, compared to 1738281600 on 7759078. Therefore, it implies a Short% of Shares Outstanding of 7154701 and a Short% of Float of 15.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
